United States Biotechnology & Medical Research

Biovie Inc (BIVI)

Track

Biovie Inc. has seen no insider trading activity within the last three months. The most recent transaction occurred on March 4, 2024, when the President and CEO acquired 10,000 shares. Prior to this, various directors and executives engaged in both buying and selling activities throughout 2023, including notable sales by director-affiliated parties in December 2023.
Ticker: BIVI Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Biovie Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.5
DO CUONG V President & CEO Executive Director
Transaction date
Purchase
Price
113.08
Quantity 20,311
Value US$1,304,449
2.6
GORLIN STEVE Non-Executive Director
Transaction date
Sale
Price
377.75
Quantity 14,380 -20.8%
Value US$2,258,904
2.6
STEVE GORLIN Director Non-Executive Director
Transaction date
Proposed sale
Price
463.34
Quantity 44,595
Value US$377,295
2.6
DEBORAH GORLIN Wife of director Steve Gorlin Non-Executive Director
Transaction date
Proposed sale
Price
1.69
Quantity 50,000
Value US$84,500
0.5
DO CUONG V President & CEO Executive Director
Transaction date
Purchase
Price
1.78
Quantity 10,000 +17.0%
Value US$17,800
2.6
GORLIN STEVE Non-Executive Director
Transaction date
Sale
Price
3.05
Quantity 8,560 -10.2%
Value US$26,108
2.6
STEVE GORLIN Director Non-Executive Director
Transaction date
Proposed sale
Price
3.05
Quantity 8,560
Value US$26,108
2.6
BERMAN RICHARD J Non-Executive Director
Transaction date
Sale
Price
3.50
Quantity 10,805 -39.2%
Value US$37,827
2.6
BERMAN RICHARD J Non-Executive Director
Transaction date
Sale
Price
5.81
Quantity 5,984 -20.5%
Value US$34,782
2.6
BERMAN RICHARD J Non-Executive Director
Transaction date
Sale
Price
6.50
Quantity 5,000 -14.6%
Value US$32,506
2.6
BERMAN RICHARD J Non-Executive Director
Transaction date
Sale
Price
8.52
Quantity 2,613 -7.1%
Value US$22,263
2.6
BERMAN RICHARD J Non-Executive Director
Transaction date
Sale
Price
8.52
Quantity 5,000 -12.0%
Value US$42,608
2.6
BERMAN RICHARD J Non-Executive Director
Transaction date
Sale
Price
8.52
Quantity 3,371 -7.5%
Value US$28,711
0.8
KIM JOANNE WENDY CFO Officer
Transaction date
Purchase
Price
5.40
Quantity 2,000 +inf%
Value US$10,798
2.6
GORLIN STEVE Non-Executive Director
Transaction date
Purchase
Price
7.95
Quantity 2,430 +5.7%
Value US$19,318
2.6
GORLIN STEVE Non-Executive Director
Transaction date
Purchase
Price
7.97
Quantity 2,570 +6.4%
Value US$20,483
2.6
GORLIN STEVE Non-Executive Director
Transaction date
Purchase
Price
9.19
Quantity 5,000 +14.2%
Value US$45,950
2.6
GORLIN STEVE Non-Executive Director
Transaction date
Purchase
Price
10.27
Quantity 100 +0.5%
Value US$1,027
2.6
GORLIN STEVE Non-Executive Director
Transaction date
Purchase
Price
10.18
Quantity 1,000 +5.0%
Value US$10,180
2.6
GORLIN STEVE Non-Executive Director
Transaction date
Purchase
Price
10.19
Quantity 4,000 +19.0%
Value US$40,760
2.6
GORLIN STEVE Non-Executive Director
Transaction date
Purchase
Price
10.10
Quantity 5,000 +19.9%
Value US$50,500
2.6
GORLIN STEVE Non-Executive Director
Transaction date
Purchase
Price
10.01
Quantity 5,000 +16.6%
Value US$50,050
2.6
GORLIN STEVE Non-Executive Director
Transaction date
Purchase
Price
9.61
Quantity 282 +1.4%
Value US$2,710
2.6
GORLIN STEVE Non-Executive Director
Transaction date
Purchase
Price
9.42
Quantity 4,718 +31.5%
Value US$44,444
2.6
GORLIN STEVE Non-Executive Director
Transaction date
Purchase
Price
10.00
Quantity 15,000 +inf%
Value US$150,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-06 2024-03-04 B Purchase
0.5
DO CUONG V

President & CEO

Executive Director
20,311
113.08
US$1,304,449 		20,311 113.08 US$1,304,449
2023-12-06 2023-12-01 S Sale
2.6
GORLIN STEVE
Non-Executive Director
14,380 -20.8%
377.75
US$2,258,904 		14,380 -20.8% 377.75 US$2,258,904
2023-12-01 2023-12-01 PrS Proposed sale
2.6
STEVE GORLIN

Director

Non-Executive Director
44,595
463.34
US$377,295 		44,595 463.34 US$377,295
2023-12-01 2023-12-01 PrS Proposed sale
2.6
DEBORAH GORLIN

Wife of director Steve Gorlin

Non-Executive Director
50,000
1.69
US$84,500 		50,000 1.69 US$84,500
2023-12-01 2023-11-30 B Purchase
0.5
DO CUONG V

President & CEO

Executive Director
10,000 +17.0%
1.78
US$17,800 		10,000 +17.0% 1.78 US$17,800
2023-09-07 2023-09-05 S Sale
2.6
GORLIN STEVE
Non-Executive Director
8,560 -10.2%
3.05
US$26,108 		8,560 -10.2% 3.05 US$26,108
2023-09-05 2023-09-05 PrS Proposed sale
2.6
STEVE GORLIN

Director

Non-Executive Director
8,560
3.05
US$26,108 		8,560 3.05 US$26,108
2023-08-24 2023-08-22 S Sale
2.6
BERMAN RICHARD J
Non-Executive Director
10,805 -39.2%
3.50
US$37,827 		10,805 -39.2% 3.50 US$37,827
2023-06-15 2023-06-07 S Sale
2.6
BERMAN RICHARD J
Non-Executive Director
5,984 -20.5%
5.81
US$34,782 		5,984 -20.5% 5.81 US$34,782
2023-06-15 2023-05-22 S Sale
2.6
BERMAN RICHARD J
Non-Executive Director
5,000 -14.6%
6.50
US$32,506 		5,000 -14.6% 6.50 US$32,506
2023-04-06 2023-03-28 S Sale
2.6
BERMAN RICHARD J
Non-Executive Director
2,613 -7.1%
8.52
US$22,263 		2,613 -7.1% 8.52 US$22,263
2023-04-06 2023-03-28 S Sale
2.6
BERMAN RICHARD J
Non-Executive Director
5,000 -12.0%
8.52
US$42,608 		5,000 -12.0% 8.52 US$42,608
2023-04-06 2023-03-27 S Sale
2.6
BERMAN RICHARD J
Non-Executive Director
3,371 -7.5%
8.52
US$28,711 		3,371 -7.5% 8.52 US$28,711
2021-12-09 2021-12-07 B Purchase
0.8
KIM JOANNE WENDY

CFO

Officer
2,000 +inf%
5.40
US$10,798 		2,000 +inf% 5.40 US$10,798
2020-12-15 2020-11-03 B Purchase
2.6
GORLIN STEVE
Non-Executive Director
2,430 +5.7%
7.95
US$19,318 		2,430 +5.7% 7.95 US$19,318
2020-12-15 2020-10-30 B Purchase
2.6
GORLIN STEVE
Non-Executive Director
2,570 +6.4%
7.97
US$20,483 		2,570 +6.4% 7.97 US$20,483
2020-10-22 2020-10-21 B Purchase
2.6
GORLIN STEVE
Non-Executive Director
5,000 +14.2%
9.19
US$45,950 		5,000 +14.2% 9.19 US$45,950
2020-10-19 2020-10-15 B Purchase
2.6
GORLIN STEVE
Non-Executive Director
100 +0.5%
10.27
US$1,027 		100 +0.5% 10.27 US$1,027
2020-10-19 2020-10-15 B Purchase
2.6
GORLIN STEVE
Non-Executive Director
1,000 +5.0%
10.18
US$10,180 		1,000 +5.0% 10.18 US$10,180
2020-10-19 2020-10-15 B Purchase
2.6
GORLIN STEVE
Non-Executive Director
4,000 +19.0%
10.19
US$40,760 		4,000 +19.0% 10.19 US$40,760
2020-10-19 2020-10-15 B Purchase
2.6
GORLIN STEVE
Non-Executive Director
5,000 +19.9%
10.10
US$50,500 		5,000 +19.9% 10.10 US$50,500
2020-10-19 2020-10-15 B Purchase
2.6
GORLIN STEVE
Non-Executive Director
5,000 +16.6%
10.01
US$50,050 		5,000 +16.6% 10.01 US$50,050
2020-10-14 2020-10-09 B Purchase
2.6
GORLIN STEVE
Non-Executive Director
282 +1.4%
9.61
US$2,710 		282 +1.4% 9.61 US$2,710
2020-10-14 2020-10-07 B Purchase
2.6
GORLIN STEVE
Non-Executive Director
4,718 +31.5%
9.42
US$44,444 		4,718 +31.5% 9.42 US$44,444
2020-10-14 2020-09-22 B Purchase
2.6
GORLIN STEVE
Non-Executive Director
15,000 +inf%
10.00
US$150,000 		15,000 +inf% 10.00 US$150,000
Explore more

More insider trading research around Biovie Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America